Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elucent Medical’s commercialized EnVisio System provides real-time, intraoperative surgical navigation using permanently implantable SmartClip markers and spatial tracking sensors to guide precise tumor removal. The next-generation EnVisio X1 platform received FDA Breakthrough Device Designation in May 2025 for its potential to improve outcomes by minimizing positive margins and reducing re-excisions during soft tissue cancer surgeries. Clinical results highlight improved accuracy and workflow efficiency for surgeons performing breast-conserving procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elucent Medical.